![Effect on heart rate of increasing albuterol dose. Heart rate did not... | Download Scientific Diagram Effect on heart rate of increasing albuterol dose. Heart rate did not... | Download Scientific Diagram](https://www.researchgate.net/publication/8541790/figure/fig2/AS:601622199693315@1520449318174/Effect-on-heart-rate-of-increasing-albuterol-dose-Heart-rate-did-not-change-after-4.png)
Effect on heart rate of increasing albuterol dose. Heart rate did not... | Download Scientific Diagram
![Nebulization therapy: finding the optimum combination of performance, features, and affordability – Page 5 Nebulization therapy: finding the optimum combination of performance, features, and affordability – Page 5](https://www.oindpnews.com/wp-content/uploads/2019/11/Table-1.png)
Nebulization therapy: finding the optimum combination of performance, features, and affordability – Page 5
![Table 5 from Continuous nebulization therapy for asthma with aerosols of beta2 agonists. | Semantic Scholar Table 5 from Continuous nebulization therapy for asthma with aerosols of beta2 agonists. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/01a92c5ac112f986887d4d53e88aa803f480ad8c/8-Table5-1.png)
Table 5 from Continuous nebulization therapy for asthma with aerosols of beta2 agonists. | Semantic Scholar
![Table 6 from Continuous nebulization therapy for asthma with aerosols of beta2 agonists. | Semantic Scholar Table 6 from Continuous nebulization therapy for asthma with aerosols of beta2 agonists. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/01a92c5ac112f986887d4d53e88aa803f480ad8c/8-Table6-1.png)
Table 6 from Continuous nebulization therapy for asthma with aerosols of beta2 agonists. | Semantic Scholar
![A randomized controlled trial of nebulized surfactant for the treatment of severe COVID-19 in adults (COVSurf trial) | Scientific Reports A randomized controlled trial of nebulized surfactant for the treatment of severe COVID-19 in adults (COVSurf trial) | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-023-47672-x/MediaObjects/41598_2023_47672_Fig1_HTML.png)
A randomized controlled trial of nebulized surfactant for the treatment of severe COVID-19 in adults (COVSurf trial) | Scientific Reports
![Albuterol Sulfate Inhalation Solution0.042% (1.25 mg*/3 mL) and 0.021% (0.63 mg*/3 mL)(*Potency expressed as albuterol, equivalent to 1.5 mgand 0.75 mg albuterol sulfate) Revised: January 2017 Rx only Albuterol Sulfate Inhalation Solution0.042% (1.25 mg*/3 mL) and 0.021% (0.63 mg*/3 mL)(*Potency expressed as albuterol, equivalent to 1.5 mgand 0.75 mg albuterol sulfate) Revised: January 2017 Rx only](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-7.jpg&id=427002)